We found for
Issues Surrounding the Estimation of the Opportunity Cost of Adopting a New Health Care Technology: Areas for Further Research
![Issues Surrounding the Estimation of the Opportunity Image](https://www.ohe.org/wp-content/uploads/2018/08/Issues-Surrounding-the-Estimation-of-the-Opportunity-Image_0.jpg)
HTA and Decision Making in Asia: How can the available resources be used most effectively to deliver high quality HTA that can be used by health system decision makers?
![HTA and decision making in asia cover page](https://www.ohe.org/wp-content/uploads/2018/03/HTA-and-decision-making-in-asia-cover-page.jpg)
Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?
![NICE CAR T front page](https://www.ohe.org/wp-content/uploads/2017/02/NICE-CAR-T-front-page.jpg)
Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)
![Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL) report cover](https://www.ohe.org/wp-content/uploads/2016/12/MCDA-Front-Cover.jpg)
How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?
![How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?](https://www.ohe.org/wp-content/uploads/2016/08/Panel1.jpg)
A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications
![A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications](https://www.ohe.org/wp-content/uploads/2016/05/Front-Page-NICE-HTA-methods-RP-FINAL_0.gif)